Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA437525
Max Phase: Preclinical
Molecular Formula: C27H36N6O3
Molecular Weight: 492.62
Molecule Type: Small molecule
Associated Items:
ID: ALA437525
Max Phase: Preclinical
Molecular Formula: C27H36N6O3
Molecular Weight: 492.62
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: COc1ccc(Cn2nnc(C(=O)NCCCCN3CCN(c4ccccc4OC)CC3)c2C)cc1
Standard InChI: InChI=1S/C27H36N6O3/c1-21-26(29-30-33(21)20-22-10-12-23(35-2)13-11-22)27(34)28-14-6-7-15-31-16-18-32(19-17-31)24-8-4-5-9-25(24)36-3/h4-5,8-13H,6-7,14-20H2,1-3H3,(H,28,34)
Standard InChI Key: FYWWZJPZGSOQHH-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 492.62 | Molecular Weight (Monoisotopic): 492.2849 | AlogP: 2.98 | #Rotatable Bonds: 11 |
Polar Surface Area: 84.75 | Molecular Species: NEUTRAL | HBA: 8 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 9 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 13.50 | CX Basic pKa: 7.93 | CX LogP: 3.42 | CX LogD: 2.78 |
Aromatic Rings: 3 | Heavy Atoms: 36 | QED Weighted: 0.41 | Np Likeness Score: -1.83 |
1. Salama I, Hocke C, Utz W, Prante O, Boeckler F, Hübner H, Kuwert T, Gmeiner P.. (2007) Structure-selectivity investigations of D2-like receptor ligands by CoMFA and CoMSIA guiding the discovery of D3 selective PET radioligands., 50 (3): [PMID:17266201] [10.1021/jm0611152] |
2. Möller D, Salama I, Kling RC, Hübner H, Gmeiner P.. (2015) 1,4-Disubstituted aromatic piperazines with high 5-HT2A/D2 selectivity: Quantitative structure-selectivity investigations, docking, synthesis and biological evaluation., 23 (18): [PMID:26299826] [10.1016/j.bmc.2015.07.050] |
Source(1):